Drawing for CHIVD CHEMCLIN DIAGNOSTICS CORPORATION

USPTO serial 88044603

CHIVD CHEMCLIN DIAGNOSTICS CORPORATION

Reviewed by CopyMark Law Group

Reg. 5882047Status 710
Filing date
Status date
Registration date
Oct 15, 2019
Examiner
MUNN LEWIS, LAKEISHA S
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with CHIVD CHEMCLIN DIAGNOSTICS CORPORATION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Charles Ho

Charles Ho Barron & Young Intellectual Property Ltd.P.O. Box 1484, General Post OfficeHong Kong,

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for thyroid disease, reproductive disease, infectious disease, autoimmune disease, tumor disease, cardiovascular disease, bone metabolic disease, diabetes, and hepatic fibrosis; biological preparations for medical purposes for the treatment of thyroid disease, reproductive disease, infectious disease, autoimmune disease, tumor disease, cardiovascular disease, bone metabolic disease, diabetes, and hepatic fibrosis; chemical preparations for pharmaceutical purposes, namely, for thyroid disease, reproductive disease, infectious disease, autoimmune disease, tumor disease, cardiovascular disease, bone metabolic disease, diabetes, and hepatic fibrosis; chemical preparations for medical purposes, namely, for thyroid disease, reproductive disease, infectious disease, autoimmune disease, tumor disease, cardiovascular disease, bone metabolic disease, diabetes, and hepatic fibrosis; biochemical drug for thyroid disease, reproductive disease, infectious disease, autoimmune disease, tumor disease, cardiovascular disease, bone metabolic disease, diabetes, and hepatic fibrosis; chemical preparations for the diagnosis of pregnancy; diagnostic preparations for medical purposes; chemical reagents for medical or veterinary purposes; enzyme preparations for medical purposes; Reagent paper, for medical or veterinary purposesSECTION 8 - CANCELLED—
010Surgical apparatus and instruments; medical apparatus and instruments for thyroid disease, reproductive disease, infectious disease, autoimmune disease, tumor disease, cardiovascular disease, bone metabolic disease, diabetes, and hepatic fibrosis; physical exercise apparatus, for medical purposes; apparatus for use in medical analysis for thyroid disease, reproductive disease, infectious disease, autoimmune disease, tumor disease, cardiovascular disease, bone metabolic disease, diabetes, and hepatic fibrosis; testing apparatus for medical purposes for testing thyroid disease, reproductive disease, infectious disease, autoimmune disease, tumor disease, cardiovascular disease, bone metabolic disease, diabetes, and hepatic fibrosis; diagnostic apparatus for medical purposes for thyroid disease, reproductive disease, infectious disease, autoimmune disease, tumor disease, cardiovascular disease, bone metabolic disease, diabetes, and hepatic fibrosis; sterilization units for medical devices; lasers for medical purposes; isotope apparatus and instruments for diagnosis and treatment, namely, chemiluminescent immunoassay; ultraviolet germicidal lamps for medical useSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 1, 2026C8..CANCELLED SEC. 8 (6-YR)—
Oct 15, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Nov 13, 2019ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Nov 5, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 5, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 15, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 30, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 30, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 10, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 26, 2019PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 25, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 25, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Jun 25, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 25, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 25, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 25, 2019ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Jun 24, 2019PBERWITHDRAWN FROM PUB - EXAMINING ATTORNEY REQUEST—
Jun 18, 2019PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 17, 2019ALIEASSIGNED TO LIE—
Jun 4, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 30, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 29, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 29, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 8, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 8, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 8, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 6, 2018DOCKASSIGNED TO EXAMINER—
Jul 25, 2018MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jul 24, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 23, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance